CClinicalTrials.gg
CompletedNCT03742362Updated Mar 3, 2020

MRI Study of the Distal Radius Bone Marrow Fat Fraction in Osteoporotic and Healthy Women

An interventional study of MRI scans of distal radius in Osteoporosis, Postmenopausal, sponsored by Uri Nevo. Completed at 1 site in Israel. Open to female participants aged 45 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-03-03.

Sponsored by Uri Nevo · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
26
Allocation
Not applicable
Ages
45 Years to 65 Years
Sex
Female
01

Study summary

The aim of the study is to test whether the distal radius bone marrow show significant difference in the fat fraction in young women compared to post menopausal women with and without osteoporosis.

Read the detailed description

Patients of the Department of Endocrinology, who routinely perform bone density tests, DXA (Dual Energy X-ray absorpiometry) test on the lumbar spine, proximal femoral and distal radius, will be invited for a visit, and after signing the informed consent form, the following data will be collected: age, BMI, first menstrual period and last menstrual period, family history of osteoporosis, history of osteoporotic fractures, smoking, alcohol use and exercise habits. In addition, blood tests will be performed: calcium phosphate, albumin, alkaline phosphatase, vitamin D level, thyroid function, LH (Luteinizing Hormone) FSH (Follicle Stimulating Hormone), Estradiol, and serum bone turnover index (CTX P1NP). Amount of blood taken: 12 ml The patients will then be sent to the Alfredo Federico Strauss Center for Computerized Neuroimaging at Tel Aviv University for an MRI study of the distal radius. The study results will be analyzed by an expert bone radiologist from the Sourasky Medical Center to reject any kind of pathology (such as a fracture, inflammation, tumor), and further analyzed for bone marrow fat fraction by Tel Aviv University researchers. In the case of abnormal findings, they will be mentioned in the report and the participants will receive recommendations from the appropriate expert.

02

Conditions studied

  • Osteoporosis, Postmenopausal

Keywords

  • Osteoporosis
  • MRI
  • distal radius
  • postmenopausal
03

In context

Osteoporosis

1,640 studies on the registry are indexed under Osteoporosis; 212 are open to participants now.

This study's enrollment of 26 is below the median of 95 across 1,133 interventional studies indexed under Osteoporosis.

Browse Osteoporosis studies →

Lead sponsor

This is the only study on the registry with Uri Nevo as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
45 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria: Women over the age of 45 with regular menstruation should be included in group 1, women over the age of 55 without menstruation for at least one year should be included in groups 2 or 3 according to the results of the bone density test. If T-Score> -2.5 will be included in group 2 and if T-Score \<-2.5 they will be included in group 3.

-

Exclusion Criteria: Women with metabolic bone disease, thyroid or pre-thyroid disease, diabetes, chronic steroid use, use of osteoporosis drugs, hormonal therapy, BMI below 20 or over 27, pregnant women and tattooed women in the area under study will not be included in the study.

-

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
26 participants (actual)

Study arms

  • Experimental
    Bone marrow fat fraction by MRI

    MRI scans of distal radius will be performed to all participants to monitor the fat fraction in bone marrow

    Device: MRI scans of distal radius

Interventions

  • DeviceMRI scans of distal radius

    MRI scans to monitor the fat fraction in the bone marrow of the distal radius

06

What researchers measure

Primary outcomes

  1. Fat fraction in bone marrow

    The bone marrow will be studied to determine the percentage of fat

    Time frame: 30 min- 1 hour

07

Study locations

1 site
  • Yael Schiffenbauer
    Tel Aviv, 6085001, Israel
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 3, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03742362
Lead sponsor
Uri Nevo
Collaborators
Tel-Aviv Sourasky Medical Center
Responsible party
Uri Nevo (Head of the Bio-Engineering Department, Tel Aviv University) — Sponsor-investigator
First posted
Nov 15, 2018
Start date
Feb 2, 2019
Primary completion
Aug 30, 2019
Completion
Dec 30, 2019
Last update
Mar 3, 2020

Study contacts

Naftali Stern, Prof
principal investigator · Sourasky Medical Center
Uri Nevo, Prof
principal investigator · Tel Aviv University
Itzhak Binderman, Prof
principal investigator · Tel Aviv University
Yael Schiffenbauer, PhD
study director · Tel Aviv University
Vanessa Rouach, MD
study director · Sourasky Medical Center
Ido Drukman, MD
study director · Sourasky Medical Center

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion